Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATCH-R rollover study of continued rucaparib access
2020-001538-37Phase 3Completed
- Sponsor
- Clovis Oncology
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of rucaparib in Nonhematologic neoplasms and retroperitoneal sarcoma (RPS), sponsored by Clovis Oncology. Started May 2021; status: completed.
02
Drugs
rucaparib
03
Conditions
Nonhematologic neoplasmsretroperitoneal sarcoma (RPS)
Beyond the preview
Go deeper on 2020-001538-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001538-37.